{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:36:35Z","timestamp":1728534995458},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lfs.2024.122919","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:38:27Z","timestamp":1721435907000},"page":"122919","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data"],"prefix":"10.1016","volume":"353","author":[{"given":"Gangjian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122919_bb0005","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2024.122919_bb0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41388-019-1026-9","article-title":"Comprehensive characterization of the rRNA metabolism-related genes in human cancer","volume":"39","author":"Cui","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2024.122919_bb0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12864-017-3906-0","article-title":"A comprehensive genomic pan-cancer classification using the cancer genome atlas gene expression data","volume":"18","author":"Li","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.lfs.2024.122919_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.122919_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030280","article-title":"Observed survival interval: a supplement to TCGA pan-cancer clinical data resource","volume":"11","author":"Xiong","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2024.122919_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910719","article-title":"The positive and negative immunoregulatory role of B7 family: promising novel targets in gastric cancer treatment","volume":"22","author":"Bolandi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122919_bb0035","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1349-7006.2010.01675.x","article-title":"GI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase","volume":"101","author":"Sakr","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2024.122919_bb0040","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma","volume":"26","author":"Gao","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.04.020","article-title":"Phase 2 study of preoperative Tislelizumab in combination with low-dose nab-paclitaxel in patients with muscle-invasive bladder cancer","author":"Wu","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.lfs.2024.122919_bb0050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1535-7163.MCT-16-0761","article-title":"New B7 family checkpoints in human cancers","volume":"16","author":"Ni","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2024.122919_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0065","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1038\/onc.2012.600","article-title":"The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2024.122919_bb0070","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1158\/1078-0432.CCR-22-2108","article-title":"A novel B7-H6-targeted IgG-like T cell-engaging antibody for the treatment of gastrointestinal tumors","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122919_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120709","article-title":"The potential of B7-H6 as a therapeutic target in cancer immunotherapy","volume":"304","author":"Mohammadi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2024.122919_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110403","article-title":"B7-H7: a potential target for cancer immunotherapy","volume":"121","author":"Su","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.122919_bb0085","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4049\/jimmunol.1700325","article-title":"ILDR2 is a novel B7-like protein that negatively regulates T cell responses","volume":"200","author":"Hecht","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0090","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1007\/s00018-011-0802-7","article-title":"B7-H6\/NKp30 interaction: a mechanism of alerting NK cells against tumors","volume":"68","author":"Kaifu","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2024.122919_bb0095","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122919_bb0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies Stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2024.122919_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2016.150656","article-title":"The emerging role of immune checkpoint inhibition in malignant lymphoma","volume":"102","author":"Hude","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.lfs.2024.122919_bb0110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-20-2584","article-title":"B7-H3: an attractive target for antibody-based immunotherapy","volume":"27","author":"Kontos","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122919_bb0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2024.122919_bb0120","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"vol. 48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2024.122919_bb0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-018-0582-8","article-title":"Next generation of immune checkpoint therapy in cancer: new developments and challenges","volume":"11","author":"Marin-Acevedo","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2024.122919_bb0135","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.febslet.2015.06.037","article-title":"ILT4 drives B7-H3 expression via PI3K\/AKT\/mTOR signalling and ILT4\/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer","volume":"589","author":"Zhang","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2024.122919_bb0140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/eji.200425518","article-title":"B7-H3 promotes acute and chronic allograft rejection","volume":"35","author":"Wang","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0145","doi-asserted-by":"crossref","first-page":"12969","DOI":"10.1073\/pnas.0405259101","article-title":"The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization","volume":"101","author":"Suh","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122919_bb0150","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.3892\/mmr.2015.4050","article-title":"B7-H3 promotes cell migration and invasion through the Jak2\/Stat3\/MMP9 signaling pathway in colorectal cancer","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2024.122919_bb0155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7150\/jca.17759","article-title":"B7-H3 promotes the migration and invasion of human bladder cancer cells via the PI3K\/Akt\/STAT3 signaling pathway","volume":"8","author":"Li","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.lfs.2024.122919_bb0160","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-15-2428","article-title":"Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy","volume":"22","author":"Picarda","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122919_bb0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7150\/ijbs.39769","article-title":"Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets","volume":"16","author":"Li","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2024.122919_bb0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4110\/in.2013.13.5.184","article-title":"Emerging co-signaling networks in T cell immune regulation","volume":"13","author":"Jung","year":"2013","journal-title":"Immune Netw."},{"key":"10.1016\/j.lfs.2024.122919_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/intimm\/dxq049","article-title":"PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1","volume":"22","author":"Ghiotto","year":"2010","journal-title":"Int. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0195","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.193.7.839","article-title":"B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells","volume":"193","author":"Tseng","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1084\/jem.20030242","article-title":"Cooperative B7-1\/2 (CD80\/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor","volume":"198","author":"Shin","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0205","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/cmi.2017.17","article-title":"B7-DC (PD-L2) costimulation of CD4+ T-helper 1 response via RGMb","volume":"15","author":"Nie","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.20100619","article-title":"VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses","volume":"208","author":"Wang","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41420-021-00628-4","article-title":"B7-H5 blockade enhances CD8+ T-cell-mediated antitumor immunity in colorectal cancer","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2024.122919_bb0220","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2004.02.004","article-title":"The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells","volume":"126","author":"Nakazawa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.122919_bb0225","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/glia.10291","article-title":"Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo","volume":"44","author":"Schreiner","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2024.122919_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.intimp.2018.01.018","article-title":"Expression of B7-H2 on CD8+ T cells in colorectal cancer microenvironment and its clinical significance","volume":"56","author":"Cao","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.122919_bb0235","first-page":"2646","article-title":"B7-H3 expression associates with tumor invasion and patient\u2019s poor survival in human esophageal cancer","volume":"7","author":"Chen","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2024.122919_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/PGP.0000000000000116","article-title":"Epithelial and tumor-associated endothelial expression of B7-H3 in cervical carcinoma: relation with CD8+ intraepithelial lymphocytes, FIGO stage, and phosphohistone H3 (PHH3) reactivity","volume":"34","author":"Brustmann","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.lfs.2024.122919_bb0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","article-title":"Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature","volume":"31","author":"Seaman","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2024.122919_bb0250","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3892\/or.2017.5858","article-title":"B7-H3 is related to tumor progression in ovarian cancer","volume":"38","author":"Zhang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.122919_bb0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41423-019-0305-2","article-title":"Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy","volume":"17","author":"Cai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0260","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.stem.2021.04.011","article-title":"CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2024.122919_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108153","article-title":"The role of B7-H3 in tumors and its potential in clinical application","volume":"101","author":"Feng","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.122919_bb0270","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni967","article-title":"The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses","volume":"4","author":"Suh","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0275","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.7150\/thno.49480","article-title":"Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2024.122919_bb0280","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1021\/acsnano.2c12217","article-title":"Engineering MMP-2 activated nanoparticles carrying B7-H3 bispecific antibodies for ferroptosis-enhanced glioblastoma immunotherapy","volume":"17","author":"Fan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.lfs.2024.122919_bb0285","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00262-011-1017-3","article-title":"B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma","volume":"60","author":"Chen","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2024.122919_bb0290","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2012.08.017","article-title":"A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer","volume":"127","author":"Fauci","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.lfs.2024.122919_bb0295","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/IGC.0b013e3181ad0fa2","article-title":"B7-H4 expression promotes tumorigenesis in ovarian cancer","volume":"19","author":"Cheng","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.lfs.2024.122919_bb0300","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20050930","article-title":"B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma","volume":"203","author":"Kryczek","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0305","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2024.122919_bb0310","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/ncomms3043","article-title":"B7-H5 costimulates human T cells via CD28H","volume":"4","author":"Zhu","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122919_bb0315","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1303524110","article-title":"HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2024.122919_bb0320","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41423-020-0361-7","article-title":"B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling","volume":"18","author":"Rieder","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2024.122919_bb0325","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/2326-6066.CIR-19-0321","article-title":"Characterization of BAY 1905254, an immune checkpoint inhibitor targeting the immunoglobulin-like domain containing receptor 2 (ILDR2)","volume":"8","author":"Huetter","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.lfs.2024.122919_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23171","article-title":"Alternative immune checkpoints in immunoregulatory profile of cancer stem cells","volume":"9","author":"Mortezaee","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2024.122919_bb0335","first-page":"2722","article-title":"B7-H3 promotes malignant progression of muscle-invasive bladder cancer","volume":"40","author":"Xu","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.122919_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094969","article-title":"Elevated expression of the immune checkpoint ligand CD276 (B7-H3) in urothelial carcinoma cell Lines correlates negatively with the cell proliferation","volume":"23","author":"Harland","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122919_bb0345","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/s41467-024-46735-5","article-title":"CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer","volume":"15","author":"Cheng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122919_bb0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2022.05.022","article-title":"B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer","volume":"171","author":"Liu","year":"2022","journal-title":"Eur. J. Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T20:55:44Z","timestamp":1728507344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524005095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":70,"alternative-id":["S0024320524005095"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122919","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122919"}}